nafamostat has been researched along with Ascites in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyasaka, Y | 1 |
Ono, K | 1 |
Nagayama, K | 1 |
Murakami, T | 1 |
Noguchi, O | 1 |
Uchihara, M | 1 |
Izumi, N | 1 |
Miyake, S | 1 |
Kubota, K | 1 |
Enomoto, N | 1 |
Tanaka, Y | 1 |
Marumo, F | 1 |
Sato, C | 1 |
1 other study available for nafamostat and Ascites
Article | Year |
---|---|
[A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascites; Benzamidines; Drug Therapy, Combination; Gastroint | 1996 |